| pubmed-article:12518237 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12518237 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:12518237 | lifeskim:mentions | umls-concept:C0005855 | lld:lifeskim |
| pubmed-article:12518237 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:12518237 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
| pubmed-article:12518237 | lifeskim:mentions | umls-concept:C0031164 | lld:lifeskim |
| pubmed-article:12518237 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:12518237 | lifeskim:mentions | umls-concept:C0073917 | lld:lifeskim |
| pubmed-article:12518237 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:12518237 | pubmed:dateCreated | 2003-1-8 | lld:pubmed |
| pubmed-article:12518237 | pubmed:abstractText | To investigate the effect of bucillamine for prevention of increasing blood-retinal barrier (BRB) permeability in streptozotocin (STZ)-induced diabetic rats. | lld:pubmed |
| pubmed-article:12518237 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12518237 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12518237 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12518237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12518237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12518237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12518237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12518237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12518237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12518237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12518237 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12518237 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:12518237 | pubmed:issn | 0271-3683 | lld:pubmed |
| pubmed-article:12518237 | pubmed:author | pubmed-author:YoshidaAkitos... | lld:pubmed |
| pubmed-article:12518237 | pubmed:author | pubmed-author:NakamuraMasao... | lld:pubmed |
| pubmed-article:12518237 | pubmed:author | pubmed-author:HikichiTaiich... | lld:pubmed |
| pubmed-article:12518237 | pubmed:author | pubmed-author:MoriFumihikoF | lld:pubmed |
| pubmed-article:12518237 | pubmed:author | pubmed-author:SasakiMaiM | lld:pubmed |
| pubmed-article:12518237 | pubmed:author | pubmed-author:ShishidoNaomi... | lld:pubmed |
| pubmed-article:12518237 | pubmed:author | pubmed-author:HorikawaYoshi... | lld:pubmed |
| pubmed-article:12518237 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12518237 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:12518237 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12518237 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12518237 | pubmed:pagination | 1-7 | lld:pubmed |
| pubmed-article:12518237 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:meshHeading | pubmed-meshheading:12518237... | lld:pubmed |
| pubmed-article:12518237 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12518237 | pubmed:articleTitle | Inhibitory effects of bucillamine on increased blood-retinal barrier permeability in streptozotocin-induced diabetic rats. | lld:pubmed |
| pubmed-article:12518237 | pubmed:affiliation | Department of Ophthalmology, Asahikawa Medical College, Asahikawa, Japan. hikichi@asahikawa-med.ac.jp | lld:pubmed |
| pubmed-article:12518237 | pubmed:publicationType | Journal Article | lld:pubmed |
